Erin go Bragh!

This particular product, which is dispensed through a vaporiser, was approved for the treatment of multiple sclerosis in Canada 17 years ago. It has been authorised in six other countries since that time and is available in Northern Ireland under the National Health Service. Delaying its availability to patients here, now that it has been recommended for use as “a valid treatment option” by the IMB, would be cruel. Discussions on how to authorise medicinal cannabinoids, while retaining existing controls on cannabis use, should be quickly resolved within the Department of Health, along with issues of cost and the range of conditions to be covered.

http://www.irishtimes.com/newspaper/opinion/2...60014.html

cheers

RFMK